Dermapharm Holding SE buy DirectorDealer
Start price
23.11.23
/
50%
€40.38
Target price
23.11.24
-
Performance (%)
-5.52%
End price
24.11.24
€38.15
Summary
This prediction ended on 24.11.24 with a price of €38.15. With a performance of -5.52%, the BUY prediction by DirectorDealer finished with a loss. DirectorDealer has a follow-up prediction for Dermapharm Holding SE where he still thinks Dermapharm Holding SE is a Buy. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dermapharm Holding SE | 4.762% | 4.762% | 22.888% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Themis Beteiligungs-Aktiengesellschaft (in enger Beziehung)
- Handelstag: 21.11.2023
- Volumen: 15216000 €
- Meldende_r: Themis Beteiligungs-Aktiengesellschaft
In the thread Trading Dermapharm Holding SE
Die von DirectorDealer gewählte maximale Laufzeit wurde überschritten